Skip to content
ABOUT US
OUR MISSION
OUR TEAM
ROADMAP
PRODUCTS
NBL-EC01-P
NBL-CY01-P
REFERENCES
NEWS
MEDIA COVERAGE
GALLERY
CONTACT US
CAREER
CONTACT US
ABOUT US
OUR MISSION
OUR TEAM
ROADMAP
PRODUCTS
NBL-EC01-P
NBL-CY01-P
REFERENCES
NEWS
MEDIA COVERAGE
GALLERY
CONTACT US
CAREER
CONTACT US
REFERENCES
All
Regulatory
Commercial
Useful Website
Date
Topic
Sep 2025
Postapproval Data Capture For Cell And Gene Therapies
Aug 2025
China's NMPA Proposes Halving Clinical Trial Review Time To 30 Days To Accelerate Drug Development
Jul 2025
European Regulatory Update: Swissmedic Pilots Accelerated Clinical Trial Review And EMA Seeks Feedback On Non-Clinical Development Lessons
Jun 2025
US FDA Eliminates REMS For Approved CAR-T Cell Immunotherapies To Enhance Patient Access
Jun 2025
China's First Systematic Regulation For Advanced Therapy Medicinal Products (ATMPs): CDE Draft Guidelines
Jun 2025
Experts Urge Regulatory Flexibility For Pediatric Cell And Gene Therapies To Accelerate Access And Innovation
April 2025
China's New Era Of Regulatory Data Protection: NMPA Draft Measures On Clinical Trial Data Exclusivity
Feb 2025
China's Evolving Biopharma Landscape: Innovations And Regulatory Modernization (2019-2023 Review)
Jan 2025
Global Cell And Gene Therapy Approvals In 2024: A Year Of Landmark "Firsts" And Therapeutic Expansion
Jan 2025
China Approves First Stem Cell Therapy
Nov 2024
China Approves MSD's Welireg For VHL Disease
Oct 2024
China's Cell Therapy Landscape: Regulatory Framework And Clinical Trial Advancement Insights
Jan 2024
Considerations For CAR T-Cell Development
Date
Topic
Sep 2025
Postapproval Data Capture For Cell And Gene Therapies
Aug 2025
China's NMPA Proposes Halving Clinical Trial Review Time To 30 Days To Accelerate Drug Development
Jul 2025
European Regulatory Update: Swissmedic Pilots Accelerated Clinical Trial Review And EMA Seeks Feedback On Non-Clinical Development Lessons
Jun 2025
US FDA Eliminates REMS For Approved CAR-T Cell Immunotherapies To Enhance Patient Access
Jun 2025
China's First Systematic Regulation For Advanced Therapy Medicinal Products (ATMPs): CDE Draft Guidelines
Jun 2025
Experts Urge Regulatory Flexibility For Pediatric Cell And Gene Therapies To Accelerate Access And Innovation
April 2025
China's New Era Of Regulatory Data Protection: NMPA Draft Measures On Clinical Trial Data Exclusivity
Jan 2024
Considerations For CAR T-Cell Development
Date
Topic
Feb 2025
China's Evolving Biopharma Landscape: Innovations And Regulatory Modernization (2019-2023 Review)
Jan 2025
Global Cell And Gene Therapy Approvals In 2024: A Year Of Landmark "Firsts" And Therapeutic Expansion
Jan 2025
China Approves First Stem Cell Therapy
Nov 2024
China Approves MSD's Welireg For VHL Disease
Oct 2024
China's Cell Therapy Landscape: Regulatory Framework And Clinical Trial Advancement Insights
Website
U.S. FOOD & DRUG ADMINISTRATION
MedPath
Scroll to Top
English
Chinese